SEC Form 4 · accession 0001213900-15-009534
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sergio Traversa
Officer — Chief Executive Officer · Director
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 9:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 15, 2015 | P | 241 | $2.92 | A | 320,593 | D | |
| Common stock | Dec 15, 2015 | P | 2,759 | $2.99 | A | 323,352 | D | |
| Common stock | Dec 15, 2015 | P | 2,370 | $2.98 | A | 325,722 | D | |
| Common stock | Dec 15, 2015 | P | 5,600 | $2.91 | A | 331,322 | D | |
| Common stock | Dec 15, 2015 | P | 4,358 | $3.00 | A | 335,680 | D | |
| Common stock | Dec 15, 2015 | P | 1,600 | $3.40 | A | 337,280 | D | |
| Common stock | Dec 15, 2015 | P | 42 | $3.39 | A | 337,322 | D | |
| Common stock | Dec 15, 2015 | P | 200 | $3.34 | A | 337,522 | D | |
| Common stock | Dec 15, 2015 | P | 1,800 | $3.42 | A | 339,322 | D |
Table II — derivative securities
No Table II lines on this filing.